Chemoinformaics analysis of (-)- 5,7-dihydroxy-2-eicosyl-chromone
Molecular Weight | 458.683 | nRot | 19 |
Heavy Atom Molecular Weight | 412.315 | nRig | 12 |
Exact Molecular Weight | 458.34 | nRing | 2 |
Solubility: LogS | -3.69 | nHRing | 1 |
Solubility: LogP | 10.191 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 79 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 1 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 29 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
No. of Oxygen atom | 4 | No. of Arom Bond | 11 |
nHA | 4 | APOL | 82.3105 |
nHD | 2 | BPOL | 48.7515 |
QED | 0.206 |
Synth | 2.502 |
Natural Product Likeliness | 0.889 |
NR-PPAR-gamma | 0.979 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.017 |
Pgp-sub | 0.001 |
HIA | 0.005 |
CACO-2 | -5.117 |
MDCK | 0.0000116 |
BBB | 0.014 |
PPB | 0.998507 |
VDSS | 5.928 |
FU | 0.00981165 |
CYP1A2-inh | 0.205 |
CYP1A2-sub | 0.167 |
CYP2c19-inh | 0.481 |
CYP2c19-sub | 0.056 |
CYP2c9-inh | 0.095 |
CYP2c9-sub | 0.994 |
CYP2d6-inh | 0.615 |
CYP2d6-sub | 0.515 |
CYP3a4-inh | 0.265 |
CYP3a4-sub | 0.021 |
CL | 3.888 |
T12 | 0.118 |
hERG | 0.311 |
Ames | 0.599 |
ROA | 0.071 |
SkinSen | 0.97 |
Carcinogencity | 0.031 |
EI | 0.971 |
Respiratory | 0.862 |
NR-Aromatase | 0.426 |
Antiviral | Yes |
Prediction | 0.723509 |